Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
ResearchAug 6, 2024Reduced Likelihood of Hospitalization With the JN.1 or HV.1 Severe Acute Respiratory Syndrome Coronavirus 2 Variants Compared With the EG.5 Variant
Press ReleasesJul 22, 2024The Ohio State University Wexner Medical Center and Helix Partner to Launch the Largest Precision Health Initiative in Ohio
Press ReleasesJun 24, 2024Helix and Recursion Pharmaceuticals Drive Drug Discovery Innovation Through Clinico-Genomic Data
Press ReleasesJun 7, 2024Helix Launches Clinico-Genomic Datasets for Cardiovascular, Metabolic, Immunology and Inflammation Disorders
WebinarsApr 25, 2024The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders
NewsApr 5, 2024Unleashing a new frontier: The power of germline clinico-genomic data to drive therapeutic development
Blog From Niche to Necessity: Precision Medicine Isn’t an Initiative. It’s the New Infrastructure.By James Lu, MD, PhD, CEO and Co-Founder of Helix
Press ReleasesHelix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine DevelopmentMarch 5, 2026
Press ReleasesHelix Partners with Mawi DNA Technologies to Expand Access to Non-Invasive Genomic Sample CollectionFebruary 10, 2026
Press ReleasesHelix Announces Multi-Year Strategic Collaboration with GSK to Drive Precision Medicine DevelopmentJanuary 7, 2026
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchPopulation Genomic Screening Improves Lipid Management in Familial HypercholesterolemiaNovember 6, 2025
2Published ResearchPopulation Genomic Screening and Improved Lipid Management in Patients With Familial HypercholesterolemiaNovember 5, 2025
3Published ResearchFrom Uncertain to Actionable: Significant Reduction in Variants of Uncertain Significance in Hereditary Germline Testing via Multi-Institutional Real-World EvidenceAugust 15, 2025
4Published ResearchNovel Method for Predicting Lp(a) From Genomic Testing Identifies ASCVD Risk Across a Diverse CohortJuly 30, 2025
5Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025